IP Verse

Amgen vs. Alexion Pharmaceuticals - APP_3053/2025

The UPC Case APP_3053/2025 was filed on 21 Jan, 2025 by the plaintiff Amgen against the defendant Alexion Pharmaceuticals.

Case Details

    Case Number:

    APP_3053/2025

    Patent Number:

    EP3167888

    Filing Date:

    21 Jan, 2025

    Proceeding Type:

    Generic

    Case Phase:

    Written Phase

    Plaintiffs:

    • Amgen

    Plaintiff Representatives:

    • Tilman MUELLER-STOY

    Defendants:

    • Alexion Pharmaceuticals

    Defendant Representatives:

    • Elena HENNECKE

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Oct 8, 2025Order-
Oct 8, 2025Action.Issueorder-
Oct 2, 2025Receipt-
Oct 2, 2025Other Document-
Oct 2, 2025Cover Sheet-
Sep 17, 2025Rectification
Sep 17, 2025Outcome Of The Order-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025Application For Rectification Ord 35478 2025-
Sep 9, 2025262.2 Application-
Sep 4, 2025Outcome Of The Order-
Sep 4, 2025Order With Grounds
Sep 4, 2025Anhoerung-
Sep 3, 202520250903 Second Instance Costs Confidentiality Reply Amgen Signed-
Aug 31, 2025Anhoerung-
Aug 28, 2025Comments-
Aug 25, 2025Anhoerung-
Aug 21, 2025Receipt-
Aug 20, 2025Exhibit Bp Kf01 Amgen 3053 2025-
Aug 20, 202520250820 Second Instance Costs Reply Amgen 3053 2025 Confidential Signed-
Aug 20, 202520250820 Confidentiality Applications 262 2 262 A Second Instance Costs Amgen Signed-
Aug 6, 2025Anhoerung-
Jul 14, 2025Comments-
Jul 2, 2025Anhoerung-
Jan 21, 2025Receipt-
Jan 20, 2025Application-
Oct 8, 2025Order-
Oct 8, 2025Action.Issueorder-
Oct 2, 2025Receipt-
Oct 2, 2025Other Document-
Oct 2, 2025Cover Sheet-
Sep 17, 2025Rectification
Sep 17, 2025Outcome Of The Order-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025Application For Rectification Ord 35478 2025-
Sep 9, 2025262.2 Application-
Sep 4, 2025Outcome Of The Order-
Sep 4, 2025Order With Grounds
Sep 4, 2025Anhoerung-
Sep 3, 202520250903 Second Instance Costs Confidentiality Reply Amgen Signed-
Aug 31, 2025Anhoerung-
Aug 28, 2025Comments-
Aug 25, 2025Anhoerung-
Aug 21, 2025Receipt-
Aug 20, 2025Exhibit Bp Kf01 Amgen 3053 2025-
Aug 20, 202520250820 Second Instance Costs Reply Amgen 3053 2025 Confidential Signed-
Aug 20, 202520250820 Confidentiality Applications 262 2 262 A Second Instance Costs Amgen Signed-
Aug 6, 2025Anhoerung-
Jul 14, 2025Comments-
Jul 2, 2025Anhoerung-
Jan 21, 2025Receipt-
Jan 20, 2025Application-
Oct 8, 2025Order-
Oct 8, 2025Action.Issueorder-
Oct 2, 2025Receipt-
Oct 2, 2025Other Document-
Oct 2, 2025Cover Sheet-
Sep 17, 2025Rectification
Sep 17, 2025Outcome Of The Order-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025Application For Rectification Ord 35478 2025-
Sep 9, 2025262.2 Application-
Sep 4, 2025Outcome Of The Order-
Sep 4, 2025Order With Grounds
Sep 4, 2025Anhoerung-
Sep 3, 202520250903 Second Instance Costs Confidentiality Reply Amgen Signed-
Aug 31, 2025Anhoerung-
Aug 28, 2025Comments-
Aug 25, 2025Anhoerung-
Aug 21, 2025Receipt-
Aug 20, 2025Exhibit Bp Kf01 Amgen 3053 2025-
Aug 20, 202520250820 Second Instance Costs Reply Amgen 3053 2025 Confidential Signed-
Aug 20, 202520250820 Confidentiality Applications 262 2 262 A Second Instance Costs Amgen Signed-
Aug 6, 2025Anhoerung-
Jul 14, 2025Comments-
Jul 2, 2025Anhoerung-
Jan 21, 2025Receipt-
Jan 20, 2025Application-
Oct 8, 2025Order-
Oct 8, 2025Action.Issueorder-
Oct 2, 2025Receipt-
Oct 2, 2025Other Document-
Oct 2, 2025Cover Sheet-
Sep 17, 2025Rectification
Sep 17, 2025Outcome Of The Order-
Sep 10, 2025Receipt-
Sep 10, 2025Outcome Of The Order-
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request-
Sep 9, 2025Application For Rectification Ord 35478 2025-
Sep 9, 2025262.2 Application-
Sep 4, 2025Outcome Of The Order-
Sep 4, 2025Order With Grounds
Sep 4, 2025Anhoerung-
Sep 3, 202520250903 Second Instance Costs Confidentiality Reply Amgen Signed-
Aug 31, 2025Anhoerung-
Aug 28, 2025Comments-
Aug 25, 2025Anhoerung-
Aug 21, 2025Receipt-
Aug 20, 2025Exhibit Bp Kf01 Amgen 3053 2025-
Aug 20, 202520250820 Second Instance Costs Reply Amgen 3053 2025 Confidential Signed-
Aug 20, 202520250820 Confidentiality Applications 262 2 262 A Second Instance Costs Amgen Signed-
Aug 6, 2025Anhoerung-
Jul 14, 2025Comments-
Jul 2, 2025Anhoerung-
Jan 21, 2025Receipt-
Jan 20, 2025Application-

More cases involving EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
ORD_35357/2025Aug 22, 2025Samsung BioepisAlexion Pharmaceuticals
App_35118/2025Aug 20, 2025Alexion Pharmaceuticals -